Ocular toxoplasmosis: an update and review of the literature.
about
Characterization of the parasite-induced lesions in the posterior segment of the eyeToxoplasma gondii down modulates cadherin expression in skeletal muscle cells inhibiting myogenesis.Importance of nonenteric protozoan infections in immunocompromised people.The role of serology in active ocular toxoplasmosis.Toxoplasma gondii infection regulates the balance of activating and inhibitory receptors on decidual natural killer cells.IL-10 reduces levels of apoptosis in Toxoplasma gondii-infected trophoblasts.CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis.Changes of inhibitory receptors on NK-92 cells and HLA-G on BeWo cells with Toxoplasma gondii infection.Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence.Experimental Models of Ocular Infection with Toxoplasma Gondii.Patients with diffuse uveitis and inactive toxoplasmic retinitis lesions test PCR positive for Toxoplasma gondii in their vitreous and bloodPrevalence of toxoplasmosis and related risk factors among humans referred to main laboratories of Urmia city, North West of Iran, 2013.Post-prophylaxis Toxoplasma chorioretinitis following donor-recipient mismatched liver transplantation.Ocular Toxoplasmosis: Controversies in Primary and Secondary PreventionOcular parasitoses and their immunology.Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.Therapy for ocular toxoplasmosis--the future.Unilateral pigmentary retinopathy--a review of literature and case presentation.Toxoplasma Gondii Infection of Chicken Embryos Causes Retinal Changes and Modulates HSP90B1 Gene Expression: A Promising Ocular Toxoplasmosis Model.Toxoplasma gondii protects against H(2)O(2) -induced apoptosis in ARPE-19 cells through the transcriptional regulation of apoptotic elements and downregulation of the p38 MAPK pathway.Effect of Toxoplasma gondii infection on the junctional complex of retinal pigment epithelial cells.Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) - Report 1: Epidemiology and Classification.Current Practices in Ocular Toxoplasmosis: A Survey of Brazilian Uveitis Specialists.Toxoplasmosis: new challenges for an old disease.A 26-year-old man with a blind spot in his left eye.The Effect of Long-term Intermittent Trimethoprim/Sulfamethoxazole Treatment on Recurrences of Toxoplasmic Retinochoroiditis: 10 Years of Follow-up.The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.The immunoprotective role of interleukin-10 in abnormal pregnancy outcome induced by Toxoplasma gondii infection.Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis.DNA topoisomerases in apicomplexan parasites: promising targets for drug discoveryToxoplasmosis
P2860
Q28072821-973998AF-B3EA-4AFB-B07F-636022B0626DQ33904826-B30F87BF-2CD8-4387-8F30-8FFEE078ACE8Q34189873-C96FE2A5-EAAD-4701-AAB6-0C7F67D393BFQ34246182-E63AD591-A000-40D0-8914-3A6FA868B6FDQ34580952-63004053-D0A4-4B61-84A7-3365A3585D1DQ34590090-7575A52E-C7EE-4B22-A1A6-C2EEED50A87AQ34646719-0964272F-3C20-447B-B1F9-DC536C6E7A76Q34843334-35D9358F-C452-4393-B2D7-D1D9A8923823Q35189546-BBC72827-A057-439D-9166-1F1FDCE4858DQ36107947-06687E25-CB6A-4B59-A0BE-37326CED7965Q36377328-7E0C0D44-3539-462C-B3A4-700F41080DE9Q37004036-0004235B-CD01-4D23-8D16-E72DCFBEBB3EQ37053258-365E126F-6415-4FB4-91B4-84815E3964BFQ37316505-1F2DA396-0308-430A-A449-46FCFA461A05Q37417245-8B6E2E21-3ABF-4806-B8A4-4D143F4A532FQ37959537-C507309A-1106-4198-929E-206B367510ACQ38024897-E8FA0F8C-C860-4334-8CB2-57FB45C83D81Q38101597-52DAFFE1-FB1B-4CBD-B6D7-0F63AACA7D36Q38843222-B6D9342E-4F58-4BD8-BDF0-797E4EE77A7CQ39294278-C5E662A3-A2B4-466A-B5B9-6392CA8AA5FCQ39579462-A9154CD3-0472-42D5-B87A-D2EB03141BC6Q39958451-312C55D4-B095-4923-88B1-133FE61CA448Q40423625-C5813D66-1A2D-4B37-8B01-23286DF5EDBDQ40550826-2D7FAD92-4E67-4E11-BC9D-52DE1D69E0ABQ40847781-EA74D047-5DE1-4917-B0FD-B7240590AB5BQ41882344-A523560C-643F-45DF-9ED3-BDD3B044A21CQ44031717-8224D148-874B-4EFF-B35C-3E0CAAA20D0CQ44696443-979F4B76-54AD-4C24-B80A-DA3A4D993470Q50776823-7AA07256-498B-4E15-B250-4D36EDBD5F7AQ55396718-3E1D18F5-7F5E-4777-882E-9B2852E6FF2AQ56432854-7C5D1B42-91CF-4B30-A5CF-FB8D12919527Q56768394-20AA6FFD-76FB-43E5-9D0C-6369BE91D958
P2860
Ocular toxoplasmosis: an update and review of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ocular toxoplasmosis: an update and review of the literature.
@en
Ocular toxoplasmosis: an update and review of the literature.
@nl
type
label
Ocular toxoplasmosis: an update and review of the literature.
@en
Ocular toxoplasmosis: an update and review of the literature.
@nl
prefLabel
Ocular toxoplasmosis: an update and review of the literature.
@en
Ocular toxoplasmosis: an update and review of the literature.
@nl
P2093
P2860
P1476
Ocular toxoplasmosis: an update and review of the literature.
@en
P2093
Alessandra G Commodaro
Claudio Silveira
Cristina Muccioli
Luiz Vicente Rizzo
Miguel N Burnier Jr
Rubens Belfort Jr
Rubens N Belfort
P2860
P304
P356
10.1590/S0074-02762009000200030
P577
2009-03-01T00:00:00Z